Pharmaxis Ltd

Pharmaxis Ltd is a specialist pharmaceutical company established to research, develop and bring to market human therapeutic products to treat chronic respiratory and autoimmune diseases.

Founded in 1998, Pharmaxis was listed on the Australian Stock Exchange in November, 2003 and is traded under the symbol PXS.

The company takes a fully integrated approach to the development of pharmaceutical products for human use and is involved in :

• the basic research, preclinical development, manufacture and release of its products;

• the design, management and control of clinical trials; and sales and marketing.

Our mission is to build an internationally successful pharmaceutical business by bringing innovative medicines to patients.

Our pipeline of products includes:

• Aridol^TM for the management of asthma;

• Bronchitol^TM for cystic fibrosis and chronic obstructive pulmonary disease (COPD);

• PXS25/64 for the treatment of multiple sclerosis; and

• PXS2076 for the treatment of rheumatoid arthritis.

Achievements since listing include:

• Successful completion of Bronchitol Phase II study in bronchiectasis patients

• Successful completion of Aridol Phase III study in asthma patients

• Acceptance by the US FDA of Aridol as an Investigational New Drug (IND)

• Lodgement of marketing application for Aridol in Australia

• Awarding of AusIndustry's Pharmaceuticals Partnerships Program (P3) grant.

The company is headquartered in Sydney at its TGA-approved manufacturing facilities.

updated 29th April, 2005

© Copyright 1996-2008 irasia.com Ltd. All rights reserved. Tel: (852) 2831-9792.

DISCLAIMER: irasia.com Ltd makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd be liable for damages resulting from the use of the information provided on this website. TRADEMARK & COPYRIGHT: All intellectual property rights subsisting in the contents of this website belong to irasia.com Ltd or have been lawfully licensed to irasia.com Ltd for use on this website. All rights under applicable laws are hereby reserved. Reproduction of this website in whole or in part without the express written permission of irasia.com Ltd is strictly prohibited. TERMS OF USE: Please read the Terms of Use governing the use of our website.